OXOMEMAZINE

Symptomatic treatment of annoying non-productive coughs, especially night-predominant coughs.

The use of a drug is not a risk factor for the use of a drug.

Pharmacotherapeutic group

Systemic antihistamines, ATC code: R06AD08.

Antihistamine H1, aliphatic lateral chain phenothiazine, characterized by:

• a marked sedative effect at usual doses, of histaminergic and central adrenolytic origin,.

• an anticholinergic effect causing peripheral side effects,.

• an peripheral adrenolytic effect, which may sound haemodynamically (risk of orthostatic hypotension), Antihistamines have the common property of opposing, by more or less reversible competitive antagonism, the effects of histamine, particularly on the skin, bronchial, intestinal, and vessel.

Pharmacological characteristics of the oxomemazine molecule cause undesirable effects of unequal intensity and dose-related or not: Psychiatric disorders:

• sedation or somnolence, more pronounced at the beginning of treatment,.

• anticholinergic effects with dry mucous membranes, constipation, accommodation disorders, mydriase, heart palpitations, risk of urinary retention,.

• orthostatic hypotension,.

• balance disorders, dizziness, decrease in memory or concentration (more common in the elderly),.

• motor incoordination, tremors,.

• mental confusion, hallucinations,.

• more rarely, excitation-type effects: agitation, nervousness, insomnia.

• erythema, eczema, purpura, urticaria, possibly giant,.

• oedema, mental confusion, hallucinations,.

• less likely, drug-type effects: agitation, nervousness, oestherapeutic disorder.

• aginasis oesmetic oes o.